The Role of a Medical Intermediate Care Unit in the Management of Budd-Chiari Syndrome: Case Series

• Autor(a) principal: Cravo, M
• Data de Publicação: 2021
• Outros Autores: Oliveira, DG, Guimas, A, Vita, P, Rego, AL, Alves, R, Valadares, D, Carvalheiras, G, Ricardo, M, Pinto, A, Pessegueiro, H, Nery, F
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
• Texto Completo: https://hdl.handle.net/10216/149570
• topic: Acute liver failure; Budd-Chiari syndrome; Hypercoagulable state

Budd-Chiari syndrome (BCS) has a wide spectrum of presentations, from an asymptomatic status to acute liver failure (ALF). The therapeutic approach depends on disease severity and related etiology with patients with severe forms of presentation classically managed in intensive care units (ICUs). Here, we report a series of five BCS patients managed in a medical intermediate care unit (IntCU), with three of them presenting with acute liver injury. Progression to ALF was seen in three patients, two of whom died, with one being successfully submitted to liver transplantation. IntCUs allow a 24-h patient surveillance and a prompt management of BCS, with less economic impact when compared to ICUs. Mortality was related to the presence of associated comorbidities that limited therapeutic approach.